Safety alerts
2 safety alerts appeared in Canada during Week 17, 2026. Safety concentration usually matters to quality, vigilance, and post-market surveillance teams because it can reveal emerging field risks.
Canada medical device regulatory intelligence, Week 17, 2026.
Signals from 2026-04-20 to 2026-04-26, covering safety alerts, regulatory changes, device registrations, market movement, and source activity for Canada.
Signals
2
Sources
2
Index status
Noindex
This report is visible for continuity, but it is excluded from search indexing until it reaches 5 qualifying signals.
EXECUTIVE SUMMARY
Canada generated 2 qualifying medical device signals during Week 17, 2026. Safety alerts led the week with 2 signals, while FDA Warning Letters was the most active source. The FDA issued a Class I recall for the Automated Impella Controller due to detection issues with the Impella pump. Honda recalls nearly 38,000 Odyssey minivans in Canada due to airbag issues.
Key observations
Safety alerts accounted for 2 of 2 qualifying signals, making it the main review lane for the week.
The remaining signals were spread across smaller categories, suggesting a lower-concentration week.
FDA Warning Letters contributed 1 signal, so source-level follow-up should start there.
Impella appeared repeatedly in the highlighted signals, which may warrant closer product, manufacturer, or competitor tracking.
Category interpretation
Recommended monitoring focus
- Review Health Canada safety and recall activity for product categories that overlap your portfolio.
- Maintain weekly monitoring for Canada, especially when low-volume weeks precede regulator database updates.
- Validate high-impact items against the original source before using them in quality or regulatory decision-making.
- Compare this week with the next completed week to separate one-off noise from sustained category movement.
Source-backed signal evidence
These source-linked items support the weekly analysis above. They are included for verification and follow-up, not as a raw feed export.
FDA Warning Letters·Safety alerts·
FDA Class I: Automated Impella Controller (AIC), used in left heart support blood pump, including the following: 1. Impella Controller, Packaged, AU; Product Code: 0042-0000-AU. 2. Impella Controller, Pack (Abiomed, Inc.)
The FDA issued a Class I recall for the Automated Impella Controller due to detection issues with the Impella pump.
SourceGDELT Medical Device Monitor·Safety alerts·
Honda recalls nearly 38 , 000 Odyssey minivans in Canada
Honda recalls nearly 38,000 Odyssey minivans in Canada due to airbag issues.
SourceSafety alerts
FDA Warning Letters·Safety alerts·
FDA Class I: Automated Impella Controller (AIC), used in left heart support blood pump, including the following: 1. Impella Controller, Packaged, AU; Product Code: 0042-0000-AU. 2. Impella Controller, Pack (Abiomed, Inc.)
The FDA issued a Class I recall for the Automated Impella Controller due to detection issues with the Impella pump.
SourceGDELT Medical Device Monitor·Safety alerts·
Honda recalls nearly 38 , 000 Odyssey minivans in Canada
Honda recalls nearly 38,000 Odyssey minivans in Canada due to airbag issues.
SourceTrack these signals continuously.
MedFlux monitors regulators and medical device market sources across priority countries so regulatory, quality, and strategy teams can review changes without manually checking agency databases.